7.24 USD
▼+0.47-0.28%
2026-08-03
市值
$260.88M
市盈率
—
EPS
-4.00
股息率
—
52 周区间
4.93 – 16.45
成交量
663.10K
Beta
-0.26
目标价
18.75
52W 低 4.9352W 高 16.45
价格走势
公司简介
Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company’s Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases. Its preclinical product includes ENTR-601-44; ENTR-601-45; and VX-670. The company was f...